Sub-Epidemics Explain Localized High Prevalence of Reduced Susceptibility to Rilpivirine in Treatment-Naive HIV-1-Infected Patients: Subtype and Geographic Compartmentalization of Baseline Resistance Mutations

Objective: The latest nonnucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine (RPV) is indicated for human immunodeficiency virus type-1 (HIV-1) patients initiating antiretroviral treatment, but the extent of genotypic RPV resistance in treatment-naive patients outside clinical trials is p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:AIDS Res Hum Retroviruses
Main Authors: Theys, Kristof, Van Laethem, Kristel, Gomes, Perpetua, Baele, Guy, Pineda-Peña, Andrea-Clemencia, Vandamme, Anne-Mieke, Camacho, Ricardo J., Abecasis, Ana B.
Format: Artigo
Jezik:Inglês
Izdano: Mary Ann Liebert, Inc. 2016
Teme:
Epidemiology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4845676/
https://ncbi.nlm.nih.gov/pubmed/26651266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2015.0095
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki